A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma
Sanjeev Khindri(Discovery Centre), Edith M. Hessel(Eligo Bioscience (France)), Andrea Ludwig-Sengpiel(Discovery Centre), Yi Cui(Kunming University of Science and Technology), Claudia Leemereise(Discovery Centre), Malcolm Begg(Discovery Centre), Mickaël Montembault(Discovery Centre), Anthony Cahn(GlaxoSmithKline (United Kingdom)), Hannah Wajdner(Discovery Centre), Oliver Kornmann(Discovery Centre), Shuying Yang(Discovery Centre), J. Hamblin(GlaxoSmithKline (United Kingdom)), Jon Robertson(Discovery Centre), Annabel Hogg(Discovery Centre)
Cited by 40
Related Papers
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
|JAMA Oncology|2017|603
Martensitic transformation and shape memory effect in ferromagnetic Heusler alloy Ni2FeGa
|Applied Physics Letters|2003|272
The Immune Subtypes and Landscape of Squamous Cell Carcinoma
|Clinical Cancer Research|2019|206
Intratumor partitioning and texture analysis of dynamic contrast‐enhanced (DCE)‐MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy
|Journal of Magnetic Resonance Imaging|2016|171
<i>MiR-125b</i> Expression Affects the Proliferation and Apoptosis of Human Glioma Cells by Targeting <i>Bmf</i>
|Cellular Physiology and Biochemistry|2009|153